查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1935755

全球咽喉痛锭剂和糖果市场（按产品类型、口味、包装类型、销售管道和最终用户划分）预测（2026-2032年）

Sore Throat Lozenges & Candy Market by Product Type, Flavor, Packaging Type, Sales Channel, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 185 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，润喉糖和糖果市场价值将达到 49.3 亿美元，到 2026 年将成长至 53.3 亿美元，年复合成长率为 8.40%，到 2032 年将达到 86.7 亿美元。

关键市场统计数据
基准年 2025 49.3亿美元
预计年份：2026年 53.3亿美元
预测年份 2032 86.7亿美元
复合年增长率 (%) 8.40%

策略实施：消费者健康趋势、监管压力和不断变化的零售业如何重塑产品开发和商业性重点。

本执行摘要探讨了影响全球咽喉糖和药用糖果市场的竞争格局、消费者趋势和产品创新趋势。近期推出的新产品和配方改良都强调了产品的多功能性，将植物成分和天然甜味剂结合，以缓解症状并增强免疫力，这不仅改变了消费者的预期，也改变了零售商的产品组合。同时，对活性成分日益严格的监管审查，以及数位化零售的快速普及，正迫使企业改善标籤、产品声明和全通路分销策略。

消费者期望的重大转变、原料创新以及全通路零售正在重新定义产品开发、证据要求和市场推广策略。

由于消费者健康意识的增强、通路的重组以及成分创新，润喉糖和糖片市场格局正在转变。消费者现在寻求的是既能缓解症状又能促进健康的配方，而不仅仅是掩盖症状的产品。这促使製造商将传统活性成分与植物萃取物和功能性补充剂结合。这种转变推动了香料製造商、植物原料供应商和临床配方开发人员之间的跨学科合作，最终加速了产品差异化的进程。

2025年美国关税调整对锭剂和锭剂类产品的采购决策、供应链韧性和商业性定价策略的影响

2025年美国关税调整的累积影响迫使许多公司重新评估其润喉糖和糖果甜点类药品的采购、製造地和跨境物流。某些进口原材料和成品关税的提高增加了到岸成本，促使企业重新评估供应商关係，导致近岸外包和双重筹资策略激增，以维持利润率的稳定性和供应的连续性。

将产品形式、分销通路特征、口味偏好、终端用户需求和包装选择与竞争优势和创新重点连结起来的综合細項分析

细分市场洞察揭示了产品、通路、口味、终端用户和包装等维度上创新、获利机会和通路效率的交汇点。依产品类型划分，市场分析涵盖硬锭剂、药糖和软锭剂。硬锭剂进一步细分为尤加利、草药萃取物和薄荷醇三种类型。这种产品分类突显了技术和感官设计方面的差异：硬锭剂通常需要配製延长与咽喉的接触时间，并平衡溶解度和活性成分的释放。而软锭剂和药糖则提供了添加适应更高水分含量成分的机会，并可创造新的质地以提升偏好。

关键区域洞察：揭示管理体制、消费者偏好特征和分销模式如何影响美洲、欧洲、中东和非洲以及亚太地区的策略。

区域趋势差异显着，影响企业必须采取的竞争策略和监管应对措施。美洲的特点是零售基础设施成熟、药房生态系统强大，以及直接面向消费者（DTC）的通路发达。监管重点包括清晰的标籤和有据可依的疗效声明，而消费者偏好也日益倾向于天然和低糖产品。美洲的转型市场仍为教育行销提供了巨大空间，可以将产品类别从缓解急性症状扩展到「健康养生」领域。

洞察竞争行为：揭示製剂技术、监管能力和策略联盟如何决定差异化、通路策略和伙伴关係活动

公司策略围绕着配方技术、市场推广策略、法规事务和品牌建立等核心竞争力。主要企业正加大对配方科学的投入，力求在功效、口感和货架稳定性之间取得平衡，同时利用合作生产伙伴关係扩大生产规模，而不损害其核心竞争力。拥有强大法规事务能力的公司在支持复杂的声明和加速跨区域产品上市方面具有优势。

实际的优先建议，帮助产品系列、证明自身价值、加强供应链，并在数位化和传统通路中取得成功

为了将洞察转化为可持续的竞争优势，产业领导者应采取一系列切实可行且基于实证的行动。首先，应优先进行产品组合最佳化，使产品与特定通路的价值提案相匹配，减少造成交易复杂性的SKU，同时专注于能够促进核心通路重复购买的产品规格和口味。其次，应透过有针对性的消费者使用研究以及在条件允许的情况下进行小规模临床检验，加快产品功效验证，从而在药房和健康管道中实现清晰的市场定位。

本报告的研究采用了一种透明、多方面的调查方法，包括一手检验、有针对性的调查、二手资料的三角验证以及品管，以检验研究结果。

本报告的研究结合了第一手资料和第二手资料，以确保研究的严谨性、可重复性和相关性。第一手资料包括对製造商、零售买家、采购主管和监管专家进行结构化访谈，以了解营运观点并检验商业性假设。此外，我们还针对具有代表性的消费者群体进行了目标调查，以探讨其购买动机、口味偏好和管道选择标准，从而补充了这些定性研究成果。

对产品创新、通路差异化和供应链韧性的全面分析，为商业决策提供清晰的指南。

总而言之，润喉糖和舒缓醣品类正处于一个转折点，产品创新、分销管道转型和供应链适应性将在此交汇，共同决定最终的商业性赢家。将经证实有效的缓解症状功效与消费者喜爱的成分和口味相结合的产品开发，将在药局和一般分销管道都获得青睐。同时，可靠的疗效证据和完善的监管准备将使真正有价值的提案在众多产品中脱颖而出。

目录

第一章：序言

第二章调查方法

  • 研究设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查前提
  • 调查限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 市场进入策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会地图
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

8. 依产品类型分類的咽喉痛润喉糖和糖果市场

  • 硬锭剂
    • 尤加利
    • 草药萃取物
    • 薄荷醇
  • 药用糖果
  • 软锭剂

9. 依口味分类的咽喉痛润喉糖和糖果市场

  • 水果
  • 草药
  • 蜂蜜
  • 薄荷醇

10. 依包装类型分類的咽喉痛润喉糖和糖果市场

  • 泡壳包装
  • 流式包装
  • 瓶子

第十一章 依销售管道分類的咽喉痛润喉糖市场

  • 便利商店
  • 网路商店
  • 药局
  • 超级市场和大卖场

第十二章 最终使用者视野下的咽喉痛润喉糖和糖果市场

  • 成人版
  • 儿童

第十三章 各地区的咽喉痛喉糖和糖果市场

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章 按群体分類的咽喉痛润喉糖和糖果市场

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

15. 各国喉咙痛润喉糖和糖果市场

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

16. 美国喉咙痛润喉糖和糖果市场

第十七章 中国润喉糖和糖果市场

第十八章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Boiron USA, Inc.
  • Church & Dwight Co., Inc.
  • GlaxoSmithKline Plc.
  • Haleon plc
  • Hyland's, Inc.
  • Johnson & Johnson Services, Inc.
  • Mondelez International, Inc.
  • Prestige Consumer Healthcare Inc.
  • Reckitt Benckiser Group plc
  • Ricola AG
  • Sanofi SA
  • Thornton & Ross Ltd.
Product Code: MRR-9A6A6F297517

The Sore Throat Lozenges & Candy Market was valued at USD 4.93 billion in 2025 and is projected to grow to USD 5.33 billion in 2026, with a CAGR of 8.40%, reaching USD 8.67 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 4.93 billion
Estimated Year [2026] USD 5.33 billion
Forecast Year [2032] USD 8.67 billion
CAGR (%) 8.40%

A strategic introduction outlining how consumer health preferences, regulatory pressures, and retail evolution are reshaping product development and commercial priorities

This executive summary introduces the competitive environment, consumer drivers, and product innovation trends shaping the global sore throat lozenges and medicinal candy category. Recent product launches and reformulation efforts have emphasized multifunctionality, combining symptomatic relief with immune-supporting botanicals and natural sweeteners, and these developments have altered both consumer expectations and retail assortments. At the same time, the interplay between regulatory scrutiny on active ingredients and accelerating digital retail adoption has required companies to refine labeling, claims, and omnichannel merchandising.

To set context, the category spans everyday symptomatic relief formats as well as perceived wellness confections that appeal to a broader health-conscious audience. Consumers are increasingly discerning about ingredient provenance, sugar content, and functional claims, while payers and pharmacy channels scrutinize efficacy statements. Concurrently, manufacturers are pursuing lightweight packaging innovations and sustainable materials to respond to both retailer requirements and end-consumer preferences.

Throughout this introduction, the goal is to orient decision-makers to the primary forces influencing product development, channel strategy, and competitive differentiation. By understanding these drivers, executives can better prioritize investments in R&D, regulatory support, and channel-specific promotion that align with evolving consumer demands and commercial realities.

Major shifts in consumer expectations, ingredient innovation, and omnichannel retailing that are redefining product development, evidence requirements, and go-to-market tactics

The landscape for sore throat lozenges and medicated candy is undergoing transformative shifts driven by consumer health awareness, channel reinvention, and ingredient innovation. Consumers now expect products that do more than mask symptoms; they seek formulations that combine relief with perceived wellness benefits, prompting manufacturers to blend traditional actives with botanical extracts and functional adjuncts. This evolution has encouraged cross-disciplinary partnerships between flavor houses, botanical suppliers, and clinical formulators, which in turn has accelerated the pace of product differentiation.

Meanwhile, retail distribution has evolved beyond traditional pharmacy and supermarket shelves. E-commerce growth and subscription models have created new avenues for direct-to-consumer engagement, enabling brands to gather first-party data and tailor communications. This shift requires novel logistics, including temperature- and humidity-aware packaging for certain formulations, and it incentivizes brands to invest in digital content that effectively communicates benefits and usage.

Regulatory and labeling expectations have tightened in several jurisdictions, prompting more rigorous evidence collection and transparent ingredient communication. In response, firms are adopting more robust claim substantiation practices and investing in clinical or consumer usage studies. Taken together, these shifts are transforming how products are conceived, validated, marketed, and delivered, creating a dynamic environment where speed-to-market and credibility are both crucial.

How the 2025 United States tariff adjustments have reshaped sourcing decisions, supply chain resilience, and commercial pricing strategies across the lozenges and medicinal candy category

The cumulative impact of tariff adjustments implemented by the United States in 2025 has prompted many firms to reassess sourcing, manufacturing footprint, and cross-border logistics for throat lozenges and confectionery-based medicinal products. Tariff increases on certain imported ingredients and finished goods raised landed costs and catalyzed a re-evaluation of supplier relationships, leading to a wave of nearshoring conversations and dual-sourcing strategies to preserve margin resilience and supply continuity.

In practice, procurement teams responded by conducting cost-to-serve analyses and by accelerating qualification processes for alternate suppliers within more favorable trade zones. Where reformulation was feasible without compromising efficacy or compliance, manufacturers evaluated domestic ingredient substitutes or modified packaging to minimize tariff exposure. For those unwilling or unable to alter supply chains quickly, companies absorbed short-term cost increases while negotiating with retailers and distributors for adjusted trade terms and promotional support.

Additionally, tariff-induced complexity increased the importance of customs classification, harmonized system codes, and tariff engineering strategies. Firms invested in enhanced tariff monitoring and scenario planning to understand implications for product portfolios and channel profitability. The net effect was a strategic pivot toward greater supply chain agility and an emphasis on commercial models that mitigate the financial and operational uncertainty introduced by the 2025 tariff landscape.

Comprehensive segmentation analysis linking product form, channel behavior, flavor preferences, end-user needs, and packaging choices to competitive advantage and innovation focus

Segment-level insight illuminates where innovation, margin opportunity, and channel effectiveness intersect across product, channel, flavor, end-user, and packaging dimensions. Based on Product Type, market is studied across Hard Lozenges, Medicinal Candy, and Soft Lozenges. The Hard Lozenges is further studied across Eucalyptus, Herbal Extract, and Menthol. This product taxonomy highlights distinct technical and sensory design constraints: hard lozenges typically emphasize prolonged throat contact and are formulated to balance dissolvability with active delivery, whereas soft lozenges and medicinal candies enable inclusion of higher moisture-compatible ingredients and novel textures aimed at palatability.

Based on Sales Channel, market is studied across Convenience Store, Online Store, Pharmacy, and Supermarket And Hypermarket. Each channel exhibits different purchase motivators and shelf velocity patterns, with pharmacies prioritizing clinically positioned SKUs, supermarkets focusing on impulse and family-size packs, convenience stores optimizing for portability and price, and online stores enabling subscription and bundling strategies. Based on Flavor, market is studied across Fruit, Herbal, Honey, and Menthol. Flavor selection directly affects trial and repeat purchase rates, with menthol and herbal profiles skewing toward therapeutic positioning while fruit and honey flavors facilitate mainstream adoption and cross-demographic appeal.

Based on End User, market is studied across Adult and Pediatric. Pediatric formulations demand stricter flavor masking, smaller dosing, and child-friendly packaging formats, creating separate formulation and regulatory pathways. Based on Packaging Type, market is studied across Blister Pack, Flow Pack, and Jar. Packaging choices influence shelf life, merchandising ergonomics, and unit economics; blister packs often support precise dosing and regulatory compliance, flow packs enable high-velocity retailing, and jars cater to multi-dose household usage. Synthesizing these segmentation lenses reveals where to focus R&D, promotional investment, and channel-specific differentiation to unlock competitive advantage.

Key regional intelligence highlighting how regulatory regimes, consumer taste profiles, and distribution models shape strategy across the Americas, Europe Middle East & Africa, and Asia-Pacific

Regional dynamics vary significantly and shape the competitive and regulatory playbooks that companies must adopt. Americas often feature a mature retail infrastructure with strong pharmacy ecosystems and a robust direct-to-consumer presence; regulatory expectations prioritize clear labeling and substantiation for therapeutic claims, while consumer preferences increasingly tilt toward natural and low-sugar options. In transitional markets within the Americas, there is still meaningful room for educational marketing to expand category usage beyond acute symptomatic relief into perceived wellness use cases.

Europe, Middle East & Africa presents a heterogeneous landscape in which regulatory regimes and distribution models differ markedly. Western European markets emphasize clinical evidence and sustainability credentials, while certain Middle Eastern and African markets prioritize affordability and distribution reach. Multinational players therefore adopt differentiated regulatory strategies and distribution partnerships, and they often tailor assortments to local palate and pricing expectations.

Asia-Pacific displays dynamic product innovation and rapid channel evolution, with pronounced growth in online pharmacy platforms and mobile-first commerce. Consumers in several Asia-Pacific markets have strong flavor preferences that influence formulation choices and localized product development. Across all regions, logistics considerations, regulatory timelines, and cultural norms shape product assortment and promotional strategy. By aligning commercial plans with these regional nuances, firms can optimize assortment, compliance, and channel investments to resonate with local demand drivers.

Insight into competitive behaviors showing how formulation skills, regulatory capabilities, and strategic collaborations determine differentiation, channel focus, and partnership activity

Company strategies cluster around a few core capabilities: formulation expertise, route-to-market proficiency, regulatory navigation, and brand building. Leading firms invest in formulation science to balance efficacy, taste, and shelf stability, while also leveraging co-manufacturing partnerships to scale production without diluting core competencies. Companies that have cultivated robust regulatory affairs functions are better positioned to support nuanced claims and accelerate product introductions across jurisdictions.

In terms of commercial positioning, some companies pursue premium, clinically validated propositions targeted at pharmacy channels, while others emphasize everyday wellness positioning distributed through supermarkets and convenience stores. Strategic collaborations between established pharmaceutical manufacturers and nimble consumer brands are increasingly common, enabling the combination of clinical credibility with agile marketing and direct-to-consumer capabilities. Similarly, acquisition activity and licensing arrangements are tools used to access niche flavors, botanical extracts, or patented delivery technologies that offer competitive differentiation.

Finally, organizations that integrate category intelligence into cross-functional decision-making - linking insights from sales, supply chain, and R&D - tend to execute more coherent launch plans and pricing strategies. These firms also have a clearer view of where to concentrate investment, whether that is in sensory science to improve palatability for pediatric lines or in sustainable packaging to meet retailer and consumer expectations.

Practical and prioritized recommendations to strengthen product portfolios, substantiate claims, fortify supply chains, and win across both digital and traditional channels

Industry leaders should pursue a set of pragmatic, evidence-based actions to convert insight into sustained competitive advantage. First, prioritize portfolio rationalization that aligns products with channel-specific value propositions, reducing SKUs that create trade complexity while doubling down on formats and flavors that drive repeat purchase in core channels. Next, accelerate claim substantiation through targeted consumer use studies and small-scale clinical validation where feasible, thereby enabling clearer positioning in pharmacy and health-oriented channels.

Simultaneously, strengthen supply chain resilience by cultivating dual-source strategies for critical actives and by evaluating nearshoring options for packaging or finished goods. Investing in tariff and customs expertise will reduce cost volatility and allow for more predictable commercial planning. On the commercial front, adopt an omnichannel content strategy that tailors messaging to discovery moments on e-commerce platforms while reinforcing credibility through pharmacist-facing educational materials in retail channels.

Finally, embed sustainability and accessibility into product and packaging roadmaps to meet evolving retailer requirements and consumer expectations. By sequencing these actions-portfolio focus, evidence generation, supply chain fortification, and omnichannel commercialization-leaders can reduce risk, improve margin resilience, and accelerate adoption of higher-value product tiers.

A transparent, multi-method research approach describing primary interviews, targeted surveys, secondary data triangulation, and quality controls that validate insights

The research underpinning this report combines primary and secondary approaches to ensure rigor, reproducibility, and relevance. Primary research included structured interviews with manufacturers, retail buyers, procurement leads, and regulatory specialists to capture operational perspectives and validate commercial assumptions. These qualitative insights were complemented by targeted surveys designed to explore purchase drivers, flavor preferences, and channel selection criteria across representative consumer cohorts.

Secondary research drew on public regulatory filings, patent and ingredient registries, industry trade publications, and retailer assortment data to map product portfolios and distribution footprints. Data synthesis employed triangulation methods to reconcile divergent findings, and quality controls included source verification, consistency checks, and peer review by subject-matter analysts. Assumptions were documented and stress-tested through scenario analysis to understand sensitivity to changes in input parameters such as raw material access or regulatory timelines.

Ethical research practices and confidentiality agreements governed primary engagement with corporate respondents, and data anonymization was used where required to protect commercial sensitivities. This layered methodological approach ensures that findings are grounded in both practitioner insight and documentary evidence, enabling robust guidance for strategic decision-making.

A conclusive synthesis that ties together product innovation, channel differentiation, and supply resilience into a clear playbook for executive decision-making

In conclusion, the sore throat lozenges and medicinal candy category is at an inflection point where product innovation, channel transformation, and supply chain adaptability converge to determine commercial winners. Product development that marries proven symptomatic relief with consumer-preferred ingredients and flavors will be favored in both pharmacy and mainstream channels, while robust claim substantiation and regulatory readiness will increasingly separate credible propositions from noise.

Channel strategies must be tailored: pharmacies will reward clinical credibility and professional endorsement, supermarkets and convenience formats will prioritize convenience and familiar flavors, and online platforms will require differentiated content and logistics capabilities. Supply chain and sourcing strategies that incorporate tariff sensitivity and alternative supplier qualification will provide the operational backbone that supports commercial agility.

Taken together, these insights point to a pragmatic playbook for executives: focus investments where product, channel, and regulatory strengths align; build operational resilience to absorb external shocks; and use targeted evidence generation to unlock premium positioning. This integrated approach will help organizations navigate complexity and capture sustainable value across the category.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Sore Throat Lozenges & Candy Market, by Product Type

  • 8.1. Hard Lozenges
    • 8.1.1. Eucalyptus
    • 8.1.2. Herbal Extract
    • 8.1.3. Menthol
  • 8.2. Medicinal Candy
  • 8.3. Soft Lozenges

9. Sore Throat Lozenges & Candy Market, by Flavor

  • 9.1. Fruit
  • 9.2. Herbal
  • 9.3. Honey
  • 9.4. Menthol

10. Sore Throat Lozenges & Candy Market, by Packaging Type

  • 10.1. Blister Pack
  • 10.2. Flow Pack
  • 10.3. Jar

11. Sore Throat Lozenges & Candy Market, by Sales Channel

  • 11.1. Convenience Store
  • 11.2. Online Store
  • 11.3. Pharmacy
  • 11.4. Supermarket And Hypermarket

12. Sore Throat Lozenges & Candy Market, by End User

  • 12.1. Adult
  • 12.2. Pediatric

13. Sore Throat Lozenges & Candy Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Sore Throat Lozenges & Candy Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Sore Throat Lozenges & Candy Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Sore Throat Lozenges & Candy Market

17. China Sore Throat Lozenges & Candy Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Boiron USA, Inc.
  • 18.6. Church & Dwight Co., Inc.
  • 18.7. GlaxoSmithKline Plc.
  • 18.8. Haleon plc
  • 18.9. Hyland's, Inc.
  • 18.10. Johnson & Johnson Services, Inc.
  • 18.11. Mondelez International, Inc.
  • 18.12. Prestige Consumer Healthcare Inc.
  • 18.13. Reckitt Benckiser Group plc
  • 18.14. Ricola AG
  • 18.15. Sanofi S.A.
  • 18.16. Thornton & Ross Ltd.

LIST OF FIGURES

  • FIGURE 1. GLOBAL SORE THROAT LOZENGES & CANDY MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL SORE THROAT LOZENGES & CANDY MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL SORE THROAT LOZENGES & CANDY MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL SORE THROAT LOZENGES & CANDY MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL SORE THROAT LOZENGES & CANDY MARKET SIZE, BY FLAVOR, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL SORE THROAT LOZENGES & CANDY MARKET SIZE, BY PACKAGING TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL SORE THROAT LOZENGES & CANDY MARKET SIZE, BY SALES CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL SORE THROAT LOZENGES & CANDY MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL SORE THROAT LOZENGES & CANDY MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL SORE THROAT LOZENGES & CANDY MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL SORE THROAT LOZENGES & CANDY MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES SORE THROAT LOZENGES & CANDY MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA SORE THROAT LOZENGES & CANDY MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL SORE THROAT LOZENGES & CANDY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL SORE THROAT LOZENGES & CANDY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL SORE THROAT LOZENGES & CANDY MARKET SIZE, BY HARD LOZENGES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL SORE THROAT LOZENGES & CANDY MARKET SIZE, BY HARD LOZENGES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL SORE THROAT LOZENGES & CANDY MARKET SIZE, BY HARD LOZENGES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL SORE THROAT LOZENGES & CANDY MARKET SIZE, BY HARD LOZENGES, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL SORE THROAT LOZENGES & CANDY MARKET SIZE, BY EUCALYPTUS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL SORE THROAT LOZENGES & CANDY MARKET SIZE, BY EUCALYPTUS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL SORE THROAT LOZENGES & CANDY MARKET SIZE, BY EUCALYPTUS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL SORE THROAT LOZENGES & CANDY MARKET SIZE, BY HERBAL EXTRACT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL SORE THROAT LOZENGES & CANDY MARKET SIZE, BY HERBAL EXTRACT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL SORE THROAT LOZENGES & CANDY MARKET SIZE, BY HERBAL EXTRACT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL SORE THROAT LOZENGES & CANDY MARKET SIZE, BY MENTHOL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL SORE THROAT LOZENGES & CANDY MARKET SIZE, BY MENTHOL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL SORE THROAT LOZENGES & CANDY MARKET SIZE, BY MENTHOL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL SORE THROAT LOZENGES & CANDY MARKET SIZE, BY MEDICINAL CANDY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL SORE THROAT LOZENGES & CANDY MARKET SIZE, BY MEDICINAL CANDY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL SORE THROAT LOZENGES & CANDY MARKET SIZE, BY MEDICINAL CANDY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL SORE THROAT LOZENGES & CANDY MARKET SIZE, BY SOFT LOZENGES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL SORE THROAT LOZENGES & CANDY MARKET SIZE, BY SOFT LOZENGES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL SORE THROAT LOZENGES & CANDY MARKET SIZE, BY SOFT LOZENGES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL SORE THROAT LOZENGES & CANDY MARKET SIZE, BY FLAVOR, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL SORE THROAT LOZENGES & CANDY MARKET SIZE, BY FRUIT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL SORE THROAT LOZENGES & CANDY MARKET SIZE, BY FRUIT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL SORE THROAT LOZENGES & CANDY MARKET SIZE, BY FRUIT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL SORE THROAT LOZENGES & CANDY MARKET SIZE, BY HERBAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL SORE THROAT LOZENGES & CANDY MARKET SIZE, BY HERBAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL SORE THROAT LOZENGES & CANDY MARKET SIZE, BY HERBAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL SORE THROAT LOZENGES & CANDY MARKET SIZE, BY HONEY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL SORE THROAT LOZENGES & CANDY MARKET SIZE, BY HONEY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL SORE THROAT LOZENGES & CANDY MARKET SIZE, BY HONEY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL SORE THROAT LOZENGES & CANDY MARKET SIZE, BY MENTHOL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL SORE THROAT LOZENGES & CANDY MARKET SIZE, BY MENTHOL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL SORE THROAT LOZENGES & CANDY MARKET SIZE, BY MENTHOL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL SORE THROAT LOZENGES & CANDY MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL SORE THROAT LOZENGES & CANDY MARKET SIZE, BY BLISTER PACK, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL SORE THROAT LOZENGES & CANDY MARKET SIZE, BY BLISTER PACK, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL SORE THROAT LOZENGES & CANDY MARKET SIZE, BY BLISTER PACK, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL SORE THROAT LOZENGES & CANDY MARKET SIZE, BY FLOW PACK, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL SORE THROAT LOZENGES & CANDY MARKET SIZE, BY FLOW PACK, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL SORE THROAT LOZENGES & CANDY MARKET SIZE, BY FLOW PACK, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL SORE THROAT LOZENGES & CANDY MARKET SIZE, BY JAR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL SORE THROAT LOZENGES & CANDY MARKET SIZE, BY JAR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL SORE THROAT LOZENGES & CANDY MARKET SIZE, BY JAR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL SORE THROAT LOZENGES & CANDY MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL SORE THROAT LOZENGES & CANDY MARKET SIZE, BY CONVENIENCE STORE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL SORE THROAT LOZENGES & CANDY MARKET SIZE, BY CONVENIENCE STORE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL SORE THROAT LOZENGES & CANDY MARKET SIZE, BY CONVENIENCE STORE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL SORE THROAT LOZENGES & CANDY MARKET SIZE, BY ONLINE STORE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL SORE THROAT LOZENGES & CANDY MARKET SIZE, BY ONLINE STORE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL SORE THROAT LOZENGES & CANDY MARKET SIZE, BY ONLINE STORE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL SORE THROAT LOZENGES & CANDY MARKET SIZE, BY PHARMACY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL SORE THROAT LOZENGES & CANDY MARKET SIZE, BY PHARMACY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL SORE THROAT LOZENGES & CANDY MARKET SIZE, BY PHARMACY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL SORE THROAT LOZENGES & CANDY MARKET SIZE, BY SUPERMARKET AND HYPERMARKET, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL SORE THROAT LOZENGES & CANDY MARKET SIZE, BY SUPERMARKET AND HYPERMARKET, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL SORE THROAT LOZENGES & CANDY MARKET SIZE, BY SUPERMARKET AND HYPERMARKET, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL SORE THROAT LOZENGES & CANDY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL SORE THROAT LOZENGES & CANDY MARKET SIZE, BY ADULT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL SORE THROAT LOZENGES & CANDY MARKET SIZE, BY ADULT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL SORE THROAT LOZENGES & CANDY MARKET SIZE, BY ADULT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL SORE THROAT LOZENGES & CANDY MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL SORE THROAT LOZENGES & CANDY MARKET SIZE, BY PEDIATRIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL SORE THROAT LOZENGES & CANDY MARKET SIZE, BY PEDIATRIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL SORE THROAT LOZENGES & CANDY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. AMERICAS SORE THROAT LOZENGES & CANDY MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 67. AMERICAS SORE THROAT LOZENGES & CANDY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 68. AMERICAS SORE THROAT LOZENGES & CANDY MARKET SIZE, BY HARD LOZENGES, 2018-2032 (USD MILLION)
  • TABLE 69. AMERICAS SORE THROAT LOZENGES & CANDY MARKET SIZE, BY FLAVOR, 2018-2032 (USD MILLION)
  • TABLE 70. AMERICAS SORE THROAT LOZENGES & CANDY MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 71. AMERICAS SORE THROAT LOZENGES & CANDY MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 72. AMERICAS SORE THROAT LOZENGES & CANDY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 73. NORTH AMERICA SORE THROAT LOZENGES & CANDY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. NORTH AMERICA SORE THROAT LOZENGES & CANDY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 75. NORTH AMERICA SORE THROAT LOZENGES & CANDY MARKET SIZE, BY HARD LOZENGES, 2018-2032 (USD MILLION)
  • TABLE 76. NORTH AMERICA SORE THROAT LOZENGES & CANDY MARKET SIZE, BY FLAVOR, 2018-2032 (USD MILLION)
  • TABLE 77. NORTH AMERICA SORE THROAT LOZENGES & CANDY MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 78. NORTH AMERICA SORE THROAT LOZENGES & CANDY MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 79. NORTH AMERICA SORE THROAT LOZENGES & CANDY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 80. LATIN AMERICA SORE THROAT LOZENGES & CANDY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. LATIN AMERICA SORE THROAT LOZENGES & CANDY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 82. LATIN AMERICA SORE THROAT LOZENGES & CANDY MARKET SIZE, BY HARD LOZENGES, 2018-2032 (USD MILLION)
  • TABLE 83. LATIN AMERICA SORE THROAT LOZENGES & CANDY MARKET SIZE, BY FLAVOR, 2018-2032 (USD MILLION)
  • TABLE 84. LATIN AMERICA SORE THROAT LOZENGES & CANDY MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 85. LATIN AMERICA SORE THROAT LOZENGES & CANDY MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 86. LATIN AMERICA SORE THROAT LOZENGES & CANDY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 87. EUROPE, MIDDLE EAST & AFRICA SORE THROAT LOZENGES & CANDY MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 88. EUROPE, MIDDLE EAST & AFRICA SORE THROAT LOZENGES & CANDY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 89. EUROPE, MIDDLE EAST & AFRICA SORE THROAT LOZENGES & CANDY MARKET SIZE, BY HARD LOZENGES, 2018-2032 (USD MILLION)
  • TABLE 90. EUROPE, MIDDLE EAST & AFRICA SORE THROAT LOZENGES & CANDY MARKET SIZE, BY FLAVOR, 2018-2032 (USD MILLION)
  • TABLE 91. EUROPE, MIDDLE EAST & AFRICA SORE THROAT LOZENGES & CANDY MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 92. EUROPE, MIDDLE EAST & AFRICA SORE THROAT LOZENGES & CANDY MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 93. EUROPE, MIDDLE EAST & AFRICA SORE THROAT LOZENGES & CANDY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 94. EUROPE SORE THROAT LOZENGES & CANDY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 95. EUROPE SORE THROAT LOZENGES & CANDY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 96. EUROPE SORE THROAT LOZENGES & CANDY MARKET SIZE, BY HARD LOZENGES, 2018-2032 (USD MILLION)
  • TABLE 97. EUROPE SORE THROAT LOZENGES & CANDY MARKET SIZE, BY FLAVOR, 2018-2032 (USD MILLION)
  • TABLE 98. EUROPE SORE THROAT LOZENGES & CANDY MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 99. EUROPE SORE THROAT LOZENGES & CANDY MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 100. EUROPE SORE THROAT LOZENGES & CANDY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 101. MIDDLE EAST SORE THROAT LOZENGES & CANDY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. MIDDLE EAST SORE THROAT LOZENGES & CANDY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 103. MIDDLE EAST SORE THROAT LOZENGES & CANDY MARKET SIZE, BY HARD LOZENGES, 2018-2032 (USD MILLION)
  • TABLE 104. MIDDLE EAST SORE THROAT LOZENGES & CANDY MARKET SIZE, BY FLAVOR, 2018-2032 (USD MILLION)
  • TABLE 105. MIDDLE EAST SORE THROAT LOZENGES & CANDY MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 106. MIDDLE EAST SORE THROAT LOZENGES & CANDY MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 107. MIDDLE EAST SORE THROAT LOZENGES & CANDY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 108. AFRICA SORE THROAT LOZENGES & CANDY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 109. AFRICA SORE THROAT LOZENGES & CANDY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 110. AFRICA SORE THROAT LOZENGES & CANDY MARKET SIZE, BY HARD LOZENGES, 2018-2032 (USD MILLION)
  • TABLE 111. AFRICA SORE THROAT LOZENGES & CANDY MARKET SIZE, BY FLAVOR, 2018-2032 (USD MILLION)
  • TABLE 112. AFRICA SORE THROAT LOZENGES & CANDY MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 113. AFRICA SORE THROAT LOZENGES & CANDY MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 114. AFRICA SORE THROAT LOZENGES & CANDY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 115. ASIA-PACIFIC SORE THROAT LOZENGES & CANDY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 116. ASIA-PACIFIC SORE THROAT LOZENGES & CANDY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 117. ASIA-PACIFIC SORE THROAT LOZENGES & CANDY MARKET SIZE, BY HARD LOZENGES, 2018-2032 (USD MILLION)
  • TABLE 118. ASIA-PACIFIC SORE THROAT LOZENGES & CANDY MARKET SIZE, BY FLAVOR, 2018-2032 (USD MILLION)
  • TABLE 119. ASIA-PACIFIC SORE THROAT LOZENGES & CANDY MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 120. ASIA-PACIFIC SORE THROAT LOZENGES & CANDY MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 121. ASIA-PACIFIC SORE THROAT LOZENGES & CANDY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL SORE THROAT LOZENGES & CANDY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 123. ASEAN SORE THROAT LOZENGES & CANDY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 124. ASEAN SORE THROAT LOZENGES & CANDY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 125. ASEAN SORE THROAT LOZENGES & CANDY MARKET SIZE, BY HARD LOZENGES, 2018-2032 (USD MILLION)
  • TABLE 126. ASEAN SORE THROAT LOZENGES & CANDY MARKET SIZE, BY FLAVOR, 2018-2032 (USD MILLION)
  • TABLE 127. ASEAN SORE THROAT LOZENGES & CANDY MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 128. ASEAN SORE THROAT LOZENGES & CANDY MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 129. ASEAN SORE THROAT LOZENGES & CANDY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 130. GCC SORE THROAT LOZENGES & CANDY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 131. GCC SORE THROAT LOZENGES & CANDY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 132. GCC SORE THROAT LOZENGES & CANDY MARKET SIZE, BY HARD LOZENGES, 2018-2032 (USD MILLION)
  • TABLE 133. GCC SORE THROAT LOZENGES & CANDY MARKET SIZE, BY FLAVOR, 2018-2032 (USD MILLION)
  • TABLE 134. GCC SORE THROAT LOZENGES & CANDY MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 135. GCC SORE THROAT LOZENGES & CANDY MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 136. GCC SORE THROAT LOZENGES & CANDY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPEAN UNION SORE THROAT LOZENGES & CANDY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 138. EUROPEAN UNION SORE THROAT LOZENGES & CANDY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPEAN UNION SORE THROAT LOZENGES & CANDY MARKET SIZE, BY HARD LOZENGES, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPEAN UNION SORE THROAT LOZENGES & CANDY MARKET SIZE, BY FLAVOR, 2018-2032 (USD MILLION)
  • TABLE 141. EUROPEAN UNION SORE THROAT LOZENGES & CANDY MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPEAN UNION SORE THROAT LOZENGES & CANDY MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 143. EUROPEAN UNION SORE THROAT LOZENGES & CANDY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 144. BRICS SORE THROAT LOZENGES & CANDY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 145. BRICS SORE THROAT LOZENGES & CANDY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 146. BRICS SORE THROAT LOZENGES & CANDY MARKET SIZE, BY HARD LOZENGES, 2018-2032 (USD MILLION)
  • TABLE 147. BRICS SORE THROAT LOZENGES & CANDY MARKET SIZE, BY FLAVOR, 2018-2032 (USD MILLION)
  • TABLE 148. BRICS SORE THROAT LOZENGES & CANDY MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 149. BRICS SORE THROAT LOZENGES & CANDY MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 150. BRICS SORE THROAT LOZENGES & CANDY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 151. G7 SORE THROAT LOZENGES & CANDY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 152. G7 SORE THROAT LOZENGES & CANDY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 153. G7 SORE THROAT LOZENGES & CANDY MARKET SIZE, BY HARD LOZENGES, 2018-2032 (USD MILLION)
  • TABLE 154. G7 SORE THROAT LOZENGES & CANDY MARKET SIZE, BY FLAVOR, 2018-2032 (USD MILLION)
  • TABLE 155. G7 SORE THROAT LOZENGES & CANDY MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 156. G7 SORE THROAT LOZENGES & CANDY MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 157. G7 SORE THROAT LOZENGES & CANDY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 158. NATO SORE THROAT LOZENGES & CANDY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 159. NATO SORE THROAT LOZENGES & CANDY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 160. NATO SORE THROAT LOZENGES & CANDY MARKET SIZE, BY HARD LOZENGES, 2018-2032 (USD MILLION)
  • TABLE 161. NATO SORE THROAT LOZENGES & CANDY MARKET SIZE, BY FLAVOR, 2018-2032 (USD MILLION)
  • TABLE 162. NATO SORE THROAT LOZENGES & CANDY MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 163. NATO SORE THROAT LOZENGES & CANDY MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 164. NATO SORE THROAT LOZENGES & CANDY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 165. GLOBAL SORE THROAT LOZENGES & CANDY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 166. UNITED STATES SORE THROAT LOZENGES & CANDY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 167. UNITED STATES SORE THROAT LOZENGES & CANDY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 168. UNITED STATES SORE THROAT LOZENGES & CANDY MARKET SIZE, BY HARD LOZENGES, 2018-2032 (USD MILLION)
  • TABLE 169. UNITED STATES SORE THROAT LOZENGES & CANDY MARKET SIZE, BY FLAVOR, 2018-2032 (USD MILLION)
  • TABLE 170. UNITED STATES SORE THROAT LOZENGES & CANDY MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 171. UNITED STATES SORE THROAT LOZENGES & CANDY MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 172. UNITED STATES SORE THROAT LOZENGES & CANDY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 173. CHINA SORE THROAT LOZENGES & CANDY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 174. CHINA SORE THROAT LOZENGES & CANDY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 175. CHINA SORE THROAT LOZENGES & CANDY MARKET SIZE, BY HARD LOZENGES, 2018-2032 (USD MILLION)
  • TABLE 176. CHINA SORE THROAT LOZENGES & CANDY MARKET SIZE, BY FLAVOR, 2018-2032 (USD MILLION)
  • TABLE 177. CHINA SORE THROAT LOZENGES & CANDY MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 178. CHINA SORE THROAT LOZENGES & CANDY MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 179. CHINA SORE THROAT LOZENGES & CANDY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)